We are delighted to welcome Dr Alan Storey as the new Editor-in-Chief of Molecular Cancer. Dr Storey is the Head of HPV Apotosis and Cancer Group at the University of Oxford with much of his research being based on the most commonly diagnosed cancer in the UK, non-melanoma skin cancer (NMSC). Dr Storey is pleased to be taking on this new role and is looking forward to building on the previous successes of the journal.
We would like to take the opportunity to thank Dr Munger who is stepping down as Editor-in-Chief. His efforts in the last two years have been crucial to the journal’s development, which is reflected in the journal’s first official impact factor of 3.69, received in 2008. We are pleased to have Dr Munger’s ongoing support for the journal as a member of the Editorial Board.
Molecular Cancer was first launched in 2002 and aims to promote the exchange of ideas, concepts and findings in any area of cancer and related biomedical science. To find out more about Molecular Cancer, please visit the journal website.
Written by Tim Allen, Acquisitions Editor.